Vascular Access Device Securement – State of the Art
WoCoVA Meet the Experts webinar recording. Watch three excellent presentations on the latest in VAD securement followed by Q&A.
Subcutaneous anchorage of PICCs – Fabrizio Brescia
Vascular Access Device (VAD) Securement in Neonates and Children – Amanda Ullman
Current Options for VAD Securement – Evan Alexandrou
SecurAcath® Awarded Innovative Technology Contract from Vizient
Vizient is the largest member-driven health care performance improvement company in the U.S. The contract was based on the recommendation of SecurAcath by hospital experts who serve on one of Vizient’s member-led councils that identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations. Vizient currently serves more than 50% of the nation’s acute care providers and 95% of the nation’s academic medical centers.
Catheter Securement Choice Does Affect Central Line-Associated Bloodstream Infection Risk
SecurAcath Significantly Reduces CLABSI Risk
Recent study in AJIC* showed an adhesive catheter securement device had a 288% increase in risk of CLABSI compared to the SecurAcath.
CLABSIs yield tremendous negative consequences affecting patients and health care facilities globally. The CDC estimates the annual cost of CLABSI is more than $1 billion, the cost per patient is more than $16,000.